Dr. Wang has over 10 years of experience in healthcare investment, with particular expertise in bio-pharmaceuticals. Dr. Wang worked at Hony Capital from 2009 to 2016, where he was responsible for biopharmaceutical investment. He also spent two years consulting at the Peking University’s International Research Centre of Medicinal Administration (a medicinal policy think-tank) as a senior fellow.
Dr. Wang graduated from Peking University Medical School with a bachelor's degree, and earned a master’s degree in pharmacology, along with a doctorate degree in biomedical sciences, from Cambridge University. He was also a research fellow at Harvard Medical School and currently serves as an adviser to the Hong Kong Innovation and Technology Fund.
South China Morning Post is a leading global news company that has reported on China and Asia for more than a century. Founded in 1903, SCMP is headquartered in Hong Kong, where it is the city’s newspaper of record, with a growing correspondent staff across Asia and the United States. SCMP's vision is to “Elevate Thought” and our mission is to “Lead the global conversation about China”. Additionally, SCMP publishes a portfolio of premium lifestyle and fashion titles in Hong Kong including Cosmopolitan,ELLE, Esquire and, Harper’s BAZAAR. SCMP is also home to Abacus, a digital news brand focused on China's tech industry; Inkstone, a daily news brief for those curious about China's growing impact around the world; and Goldthread, a content platform with a focus on food, travel and culture in China.